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The human embryonic kidney 293 (HEK-293) cells are commonly used as host for the
heterologous expression of membrane proteins not least because they have a high
transfection efficiency and faithfully translate and process proteins. In addition, their
cell size, morphology and division rate, and low expression of native channels are
traits that are particularly attractive for current-voltage measurements. Nevertheless,
the heterologous expression of complex membrane proteins such as receptors and ion
channels for biological characterization and in particular for single-cell applications such
as electrophysiology remains a challenge. Expression of functional proteins depends
largely on careful step-by-step optimization that includes the design of expression
vectors with suitable identification tags, as well as the selection of transfection
methods and detection parameters appropriate for the application. Here, we use the
heterologous expression of a plant potassium channel, the Arabidopsis thaliana guard
cell outward-rectifying K+ channel, AtGORK (At5G37500) in HEK-293 cells as an
example, to evaluate commonly used transfection reagents and fluorescent detection
methods, and provide a detailed methodology for optimized transient transfection and
expression of membrane proteins for in vivo studies in general and for single-cell
applications in particular. This optimized protocol will facilitate the physiological and
cellular characterization of complex membrane proteins.
Keywords: transfection, heterologous expression, membrane proteins, human embryonic kidney 293 cells,
fluorescent imaging, electrophysiology
INTRODUCTION
Mammalian cells such as the human embryonic kidney 293 (HEK-293) and the Chinese hamster
ovary (CHO) cells are widely used as hosts to express recombinant proteins to study their structural,
biophysical, and pharmacological properties (Baldi et al., 2007; Dalton and Barton, 2014). HEK-293
cells in particular are an attractive heterologous system for expression of membrane proteins not
least because they have post-translational modification machineries required for the proper folding
and/or optimal biological activity of target proteins. They also exhibit high transfection efficiency,
faithful translation, and processing of proteins (Wurm, 2004) that will result in higher protein
yields (Backliwal et al., 2008a) as compared to other mammalian cells, e.g., CHO cells (Bollin
et al., 2011). These attributes together with the cell size, morphology, rapid division rate, the
ease of maintenance, and the low expression of native channels as well as the capacity to express
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transgenic receptor proteins and ion channels with high fidelity
(Thomas and Smart, 2005), have established HEK-293 cells as a
host of choice for transient heterologous expression ofmembrane
proteins for structural studies (Nettleship et al., 2008; Chaudhary
et al., 2011; Andrell and Tate, 2013), biopharmaceutical (Thomas
and Smart, 2005; Jager et al., 2013), and electrophysiology
applications (Lemtiri-Chlieh and Ali, 2013).
Despite these advantages, high-level expression of complex
membrane proteins such as ion channels and trans-membrane
receptors originating from a different species for current-voltage
measurements has remained a challenge (Gan et al., 2006;
Allen et al., 2009). For electrophysiology in particular, a high
expression of proteins is critical for single-cell current recordings
in the whole-cell mode. Membrane protein biosynthesis in the
host is limited by the different composition of lipid bilayers
between human and other species that may prevent proper
folding of expressed proteins into their functional native three-
dimensional conformations. As such, optimization of plasmids,
culture media, growth conditions, or combinations thereof have
been undertaken in the past to enhance the expression of
membrane proteins (for review, see Jäger et al., 2015). These
include the introduction of mild hypothermia (Wulhfard et al.,
2008; Lin et al., 2015) and the addition of inhibitors of histone
deacetylase to the culture media (Fan et al., 2005; Backliwal
et al., 2008b). In addition to the essential elements required
for the expression of recombinant protein, vectors can also
be synthetically engineered to include optimized introns and
codon usage (Gustafsson et al., 2004) and post-transcriptional
regulatory elements (Mariati et al., 2010) to increase yields by
stabilizing recombinant transcripts.
The delivery of the recombinant vector into the host cell
and the detection of expressed proteins are the two critical
stages crucial to the expression and study of recombinant
proteins in HEK-293 cells. Recombinant proteins expressed in
transiently transfected cells can be identified with a method
that requires the simultaneous co-transfection of a lymphocyte
surface marker antigen (CD8-alpha) or a fluorescent protein
plasmid in addition to a second expression vector that contains
the gene of interest (Lemtiri-Chlieh and Ali, 2013). This method
enables visual identification of individual cells decorated with
anti-CD8 antibody coated polystyrene beads (Jurman et al.,
1994; Fortin and Hugo, 1999) under the light microscope or
fluorescence detection of cells co-expressing the fluorescent
proteins (Bestvater et al., 2002; Lin et al., 2015) and has been
used for the study of ion channels and receptor proteins including
the mammalian N-methyl-D-aspartate (NMDA; Ehlers et al.,
1996) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptors (Swanson et al., 1997; Lin et al., 2015),
the Arabidopsis thaliana cyclic nucleotide-gated ion channels
(AtCNGCs) (Leng et al., 2002; Hua et al., 2003) and Arabidopsis
K+ transporters (AKTs) (Lacombe et al., 2000; Cherel et al.,
2002). While simple, rapid and inexpensive, expression of the
CD8-alpha marker antigen or the fluorescent protein in the
transfected cells has no direct correlation with the transfection
efficiency and expression of the recombinant protein as the
success rate of the introduction of both these marker and
target gene expression vectors into the cells may be highly
variable. Recent methods using fluorescent tags such as a dye-
sensitive epitope (Tour et al., 2003; Rudner et al., 2005) or a
fluorescent protein fusion (Snapp, 2005) provide a direct and
better correlation between fluorescent signal and transfection
efficiency and protein expression level although fusion tags
such as fluorescent proteins may cause structural constrains
that interfere with protein function. These fluorescent detection
approaches have enabled successful expression of a number of
membrane proteins including the connexin-43 (Gaietta et al.,
2002), the AMPA receptors (Ju et al., 2004), the G protein-
coupled receptors (Hoffmann et al., 2005) and the human
ether-a-go-go-related gene (hERG) channel (Claassen et al.,
2008; Huang et al., 2011) that were subsequently used for
protein localization and trafficking as well as current-voltage
measurement studies.
Although the expression of several membrane proteins
and ion channels in HEK-293 cells have been reported
previously, a detailed authoritative protocol that describes the
key stages in the transient transfection and in-cell detection
of recombinant proteins optimized for single-cell applications,
is currently lacking. Here, we use the transient expression
of an A. thaliana guard cell outward-rectifying K+ channel,
AtGORK (At5G37500) in HEK-293 cells as an example to assess
current commonly used transfection reagents and the fluorescent
detection methods, and provide a specific protocol that is easily
accessible for the general expression of membrane proteins in
HEK-293 cells suitable for biological characterization. As an
example, AtGORK represents: (1) a difficult to express multi-pass
membrane protein, (2) originates from a different species, and
(3) needs to assemble into a heteromeric complex to achieve
functionality. These three characteristics can hamper optimal
expression of membrane proteins in HEK cells. In addition
to this authoritative step-by-step protocol, we also include
cautionary measures, and propose optimization strategies and
recommendations extendable and amendable for different
applications or proteins.
MATERIALS AND EQUIPMENT
Cell Line
- Human Embryonic Kidney 293 (293FT) cell line (Cat. no.
R70007, Life Technologies, Carlsbad, CA). The 293F cell line
is a fast-growing variant of the 293 cell line originally obtained
from Robert Horlick at Pharmacopeia while the 293T cell line
is a variant of 293 cells that harbors the SV40 large T antigen
which can bind to SV40 enhancers of expression vectors to
increase protein production. Here, we use the 293FT cell line
to leverage on both the “fast growing” and “increased protein
production” benefits.
Culture Media
- Dulbecco’s Modified Eagle’s medium, DMEM (1X) +
GlutaMAXTM-I (Cat. no. 31966021, Life Technologies Europe
BVM, Bleiswijk, Netherlands).
- 10% (v/v) Fetal Bovine Serum (Cat. no. 16000044, Life
Technologies, Carlsbad, CA).
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- 1 (v/v) % Penicillin-Streptomycin (10,000 U/mL; Cat.
no. 15140122, Life Technologies Europe BVM, Bleiswijk,
Netherlands).
- Opti-MEM R© I Reduced Serum medium (Cat. no. 31985062,
Life Technologies, Carlsbad, CA).
- Freezing medium consisting of 95% (v/v) complete medium
and 5% (v/v) DMSO.
Cloning Cells
- One Shot R© Mach1TM T1 phage-resistant chemically
competent E. coli cells (Cat. no. C862003, Life Technologies,
Carlsbad, CA).
Vectors
- Gateway R© pDONRTM221Vector (Cat. no. 12536017, Life
Technologies, Carlsbad, CA).
- pcDNATM6.2/cLumioTM-DEST (Cat. no. 12589016, Invitrogen
Corporation, Carlsbad, CA).
- pcDNATM6.2/nLumioTM-GW/p64 (Cat. no. 12589016,
Invitrogen Corporation, Carlsbad, CA).
- Vivid ColorsTM pcDNATM6.2/EmGFP-DEST Gateway R© vector
(Cat. no. V35520, Life Technologies, Carlsbad, CA).
- Vivid Colors pcDNA6.2/C-terminal tagged EmGFP/GW/CAT
plasmids (Cat. no. V35520, Life Technologies, Carlsbad, CA).
Chemicals/Reagents
- Lipofectamine R© 2000 (Cat. no. 11668019, Life Technologies,
Carlsbad, CA).
- Lipofectamine R© 3000 (Cat. no. L3000015, Life Technologies,
Carlsbad, CA).
- FuGENE R© HD formulation (Cat. no. E2311, Promega,
Madison, WI).
- 0.25% Trypsin-EDTA solution (Cat. no. T4049, Sigma-Aldrich
Chemie GmbH, Steinheim, Germany).
- 0.4% Trypan Blue stain (Cat. no. T10282, Life Technologies,
Carlsbad, CA).
- 50µg/mL poly-D-lysine hydrobromide (Cat. no. P0899,
Sigma-Aldrich, St. Louis, MO).
- Gateway R© LR Clonase R© II Enzyme Mix (Cat. no. 11791100,
Invitrogen, Carlsbad, CA).
- InvitrogenTM PureLink R© HQ Mini Plasmid Purification kit
(InvitrogenTM, ThermoFisher Scientific, Carlsbad, CA).
- LB broth (Lennox) (Cat. no. L3022, Sigma-Aldrich Chemie
GmbH, Steinheim, Germany).
- Carbenicillin disodium salt (Cat. no. C3416, Sigma-Aldrich
Chemie GmbH, Steinheim, Germany).
- LumioTM Green In-Cell Detection kit (Cat. No. 12589057, Life
Technologies, Carlsbad, CA).
- 10X Phosphate Buffered Saline (PBS) solution (Cat. No. P5493,
Sigma-Aldrich, St. Louis, MO).
- TRIzol R© reagent (Cat. No. 15596026, Life Technologies,
Carlsbad, CA).
- Applied BiosystemsTM High-Capacity cDNA Reverse
Transcription Kit (Cat.no. 4368814, Life Technologies,
Carlsbad, CA).
- KAPA Taq PCR kit (Cat. no. KR0352, KAPA Biosystems,
Wilmington, MA).
- Dimethyl sulfoxide (Cat. no. D8418, Sigma-Aldrich Chemie
GmbH, Steinheim, Germany).
- Acetone (Cat. no. 320110, Sigma-Aldrich, St. Louis, MO).
- Absolute ethanol (Cat. no. 32205, Sigma-Aldrich, St. Louis,
MO).
- Chloroform (Cat. no. 528730, Sigma-Aldrich Chemie GmbH,
Steinheim, Germany).
- 2-Propanol (Cat. no. I9516, Sigma-Aldrich Chemie GmbH,
Steinheim, Germany).
- DEPC-treated water (Cat. no. 95284, Sigma-Aldrich Chemie
GmbH, Steinheim, Germany).
Buffer Preparation
a) Intracellular solution consisting of 100mM KCl, 25mM
N-methyl-D-glucamine, 10mM HEPES, 10mM EGTA,
1mM CaCl2, and 4mM MgCl2 at pH 7.30 and at 280 ±
5 mOsm (osmolarity is adjusted by adding sorbitol). This
solution is prepared a day before the patch-clamp experiment,
filter sterilized through a 0.22µm Stericup-GP and stored
at 4◦C.
b) External bath solution contained 10mM KCl, 145mM
N-methyl-D-glucamine, 20mM HEPES, 10mM glucose,
0.5mM CaCl2, and 1mM MgCl2 at pH 7.30 and at 310 ±
5 mOsm (osmolarity is adjusted by adding sorbitol). This
solution is prepared a day before the patch-clamp experiment,
filter sterilized through a 0.22µm Stericup-GP and stored
at 4◦C.
Apparatus/Equipment
- 75 cm2, 250mL Cellstar R© cell culture flask (T-75; Cat. no.
658175, Greiner Bio-One GmbH, Frickenhausen, Germany).
- Corning R© Costar R© 6 well cell culture plates (Cat. no. 64705-01,
Corning Inc., Brooklyn, NY).
- 15mL FalconTM conical centrifuge tubes (Cat. no. 14-959-70C,
Corning Inc., Brooklyn, NY).
- Cryovials (Thermo Fisher Scientific, Waltham, MA).
- Stericup-GP, 0.22µm, polyethersulfone, radio-sterilized (Cat.
no. SCGPU05RE, Merck Millipore, Danver, MA).
- Countess R© II Automated Cell Counter (Cat. no. AMQAX1000,
Life Technologies, Carlsbad, CA).
- 5004 MICRO-OSMETTETM automatic high sensitivity 50µL
osmometer (PSi Precision Systems Inc., Natick, MA).
- FisherbrandTM 12mm circle cover glasses (Cat. no. 12-545-80,
Fisher Scientific, Marietta, OH).
- Thick/standard wall borosilicate glass capillaries (Cat. no.
B150-86-10, Sutter Instrument R©, Novato, CA).
- Fluorescence microscope (Nikon Eclipse TS100, Melville, NY).
- P-1000 FLAMING/BROWN micropipette puller (Sutter
instrument, Novato, CA).
- Microforge (Cat. no. MF-830, Narishige Group, Japan).
- Inverted microscope Carl Zeiss Axio Observer.A1 (Carl Zeiss,
Oberkochen, Germany).
- MultiClampTM 700B microelectrode amplifier (Axon
Instruments, Molecular Devices, Sunnyvale, CA).
- Veriti R© 96-Well Thermal Cycler (Cat. no. 4375786, Applied
BiosystemsTM, ThermoFisher Scientific, Carlsbad, CA).
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- New BrunswickTM Excella R© E23/E24R benchtop incubator
shaker (Eppendorf AG, Hamburg, Germany).
- 5% carbon dioxide (CO2) humidified growth incubator (Series
CB, BINDER, Tuttlingen, Germany).
- Water bath (VWR International, Radnor, PA).
- PrecisionTM compact ovens (Thermo Fisher Scientific,
Marietta, OH).
- Nanodrop (Thermo Fisher Scientific, Marietta, OH.
PROCEDURE
Design of Plasmid Construct (2–3 Days)
1. Both pcDNATM6.2/cLumioTM-DEST and Vivid ColorsTM
pcDNATM6.2/EmGFP-DEST Gateway R© vector (Figure S1)
are selected as the expression vectors to heterologously
express the full-length A. thaliana GORK channel (AtGORK)
(At5G37500) in HEK-293 cells.
2. The LumioTM tag consisting of 6 amino acids is located at
27 amino acid residues downstream of the C-terminal of
AtGORK (Figure S1A). The LumioTM tag contains a tetra-
cysteine motif (Cys-Cys-Pro-Gly-Cys-Cys) that forms an
arsenical hairpin detectable by interactions with biarsenical
labeling reagents (e.g., LumioTM Green or LumioTM Red;
Griffin et al., 1998; Adams et al., 2002).
3. The Emerald Green Fluorescent Protein (EmGFP) derived
from Aequorea victoria GFP (Tsien, 1998) is C-terminally
tagged at the end of the AtGORK sequence in the mammalian
expression clone (Figure S1B). v Troubleshooting (Table 2).
4. Perform codon optimization of AtGORK sequences using
the GeneOptimizer R© software. m CRITICAL STEP This step
maximizes the expression of AtGORK in the mammalian
expression system. v Troubleshooting (Table 2).
5. Assemble the codon optimized AtGORK sequences from
synthetic oligonucleotides and/or PCR products using the
GeneArtTM Gene Synthesis service offered by ThermoFisher
Scientific. •OPTIONAL Alternatively, this step can be carried
out using the conventional PCR cloning method.
Cloning, Transformation and Plasmid
Purification (4–5 Days)
6. Clone the optimized AtGORK fragment into a Gateway R©
pDONRTM221 entry vector.
7. Perform a LR recombination reaction between the entry
vector and the pcDNATM6.2/cLumioTM-DEST or the Vivid
ColorsTM pcDNATM6.2/EmGFP-DEST Gateway R© vector
using the Gateway R© LR Clonase R© II Enzyme Mix following
the manufacturer’s protocol.
8. Transform the pcDNATM6.2/cLumioTM-DEST and
Vivid ColorsTM pcDNATM6.2/EmGFP-DEST Gateway R©
expression vectors containing the AtGORK insert into One
Shot R© Mach1TM-T1R phage-resistant chemically competent
E. coli cells following the manufacturer’s transformation
procedure.
9. Inoculate a single, overnight colony in 5mL of selective LB
broth containing 50µg/mL carbenicillin and shake at 37◦C
overnight before isolating the plasmid.
10. Isolate and purify high quality plasmid DNA using the
InvitrogenTM PureLink R© HQ Mini Plasmid Purification kit
according to the manufacturer’s instructions. m CRITICAL
STEP This step provides a good yield of high-quality plasmid
DNA for use in mammalian cell transfections.
11. Analyze both the plasmid constructs by sequencing to verify
that the insertion of AtGORK into the expression vectors is
in-frame and error-free.
Growth and Maintenance of the 293FT Cell
Line (2–3 Days)
m CRITICAL STEP Culture media and trypsin-EDTA solution
should be pre-warmed in the water bath at 37◦C.
 CAUTION Handle the cell line as potentially bio-hazardous
material under at least Biosafety Level 2 containment.
12. Remove the vial of frozen cells from −140◦C freezer and
thaw quickly in a 37◦C water bath.
13. Transfer the cells to T-75 cm2 culture flask containing
11mL of complete medium consisting of Dulbecco’s
modified Eagle’s medium, DMEM (1X) + GlutaMAXTM-I
supplemented with 10% (v/v) fetal bovine serum and 1%
(v/v) penicillin-streptomycin (10,000 U/mL). v CRITICAL
STEP Ensure that all solutions and equipment that come
in contact with the cells are sterile by performing the work
in a laminar flow hood and always practice good aseptic
technique.
14. Maintain the cell culture at 37◦C in a 5% CO2 humidified
growth incubator. Replace with fresh, complete medium 24 h
after seeding. mCRITICAL STEP Replacement with fresh,
complete medium upon overnight seeding is important to
remove residual DMSO contained in the freezing medium.
 CAUTION DMSO is toxic to cell growth.
15. Incubate the cells until they are 80–90% confluent.
mCRITICAL STEP Pass the 293FT cells when they are≥80%
confluent to avoid cell overgrowth.
Transient Transfection and Heterologous
Expression of AtGORK in 293FT Cells
(1 Day)
m CRITICAL STEP We recommend using early-passage cells
for transfection experiments. Cells should be at the appropriate
confluence and at>90% viability prior to transfection.
16. Remove all medium from the flask and add 2mL of 0.25%
trypsin-EDTA solution to the adherent monolayer and
incubate 1–5min at 37◦C in a 5% CO2 humidified growth
incubator until the cells detach. Check the cells under a
microscope to confirm that most of the cells have been
detached from the bottom surface of the flask. Increase the
incubation time if the cells are still attached.
17. Add 6mL of complete medium to the cell suspension and
mix gently. mCRITICAL STEP This step is to inactivate the
trypsin activity as serum contains inhibitors of trypsin.
18. Determine cell viability using trypan blue exclusion and total
cell count using a cell counter (e.g., Countess R© II Automated
Cell Counter).
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19. Dilute the cell density to a total of 2.5× 105 viable cells/2mL
in pre-warmed complete medium for the transfection
protocol. •OPTIONAL the final cell density for transfection
protocol varies depending on the purpose of experiment.
Here, we recommend an optimal cell density of 2.5 × 105
viable cells/2mL in order to select for single cell expressing
the channel protein for current-voltage measurements. v
Troubleshooting (Table 2).
20. Seed the remaining cells at a total density of 1 × 106 viable
cells in a T-75 cm2 flask containing 11mL of pre-warmed
complete medium and maintain the cells as adherent
monolayer cultures at 37◦C in a 5% CO2 incubator for cell
establishment.
21. Once the cells have been established, we recommend freezing
some cells for storage and for future use by freezing the
cells at a density of at least 3 × 106 viable cells/ mL and at
>90% viability in labeled cryovials containing the freezing
medium. mCRITICAL STEP Prepare fresh freezing medium
immediately before use.
22. Clean the 12mm circle cover glasses by placing the coverslips
in a 50mL beaker containing acetone and swirl the beaker
gently to ensure that all the coverslips are immersed in
acetone. Incubate overnight in a fume hood.  CAUTION
Acetone is a highly flammable and toxic material that should
only be used in a fume hood.
23. Discard the acetone solution and wash the coverslips thrice
by rinsing with absolute ethanol. Repeat step 22 by replacing
acetone with absolute ethanol.  CAUTION Ethanol is a
highly flammable and toxic solvent that should only be used
in a fume hood.
24. Discard the ethanol solution and wash the coverslips thrice
by rinsing with sterile water. Dry the clean coverslips by
incubating in an oven at 65◦C overnight. Store the clean
coverslips at room temperature.
25. Place four clean coverslips in a well of a 6-well, flat bottom
cell culture plate and coat the coverslips with 2mL of
50µg/mL poly-D-lysine hydrobromide at 37◦C overnight.
Discard the poly-D-lysine hydrobromide solution and wash
the coated coverslips thrice with sterile water prior to
transfection. mCRITICAL STEP Coating of coverslips with
poly-D-lysine facilitates the cell attachment to the surface
of coverslips by promoting the electrostatic interactions
between the cell membrane and the polyamino acids on the
culture surface. v Troubleshooting (Table 2).
26. We use cationic lipid-based transfection reagents (Felgner
and Ringold, 1989), Lipofectamine R© 2000, Lipofectamine R©
3000, and non-liposomal FuGENE R© HD formulation to
transiently transfect the 293FT cells with 2.5µg of AtGORK
plasmid obtained in step 10 according to the respective
manufacturer’s instructions (Table 1). mCRITICAL STEP
Equilibrate the transfection reagents to room temperature
before use and mix by inverting or through a brief vortex. •
OPTIONALWe recommend the use of OPTI-MEM R© I (1X)
Reduced Serum Medium as diluent in all transfection steps.
Alternatively, serum-free DMEM (1X) + GlutaMAXTM-I
medium can be used for the transfection protocol. v
Troubleshooting (Table 2).
TABLE 1 | Lipid-mediated transient transfection experimental parameters
and conditions.
Component per well FuGENE® HD Lipofectamine®
2000 3000
293FT cell number/ 2mL 2.5× 105 cells 2.5× 105 cells 2.5× 105 cells
(i) Transfection reagent
OPTI-MEM® I medium 100µL 125µL 125µL
Transfection reagent 10µL 12.5µL 7.5µL
(ii) DNA component
OPTI-MEM® I medium Up to 100µL Up to 125µL Up to 125µL
Plasmid DNA 2.5µg 2.5µg 2.5µg
*P3000TM reagent N/A N/A 5µL
Incubation time at RT 15min 5min 5min
*Applicable only for transfections using the Lipofectamine® 3000 reagent.
27. The “reverse” transfection method entails adding the DNA-
lipid complex in a drop-wise manner directly to the cell
suspension containing total viable cells of 2.5 × 105/2mL
in a 15mL centrifuge tube. Mix gently by pipetting up and
down. Transfer the cell mixture to a well of 6-well culture
dish containing the coated coverslips obtained in step 25.
mCRITICAL STEP The DNA-lipid complex should be added
in a drop-wise manner directly to the cell suspension without
touching the walls of the tube prior to mixing by gentle
pipetting and followed by plating and culturing overnight at
37◦C in a 6-well culture dish. v Troubleshooting (Table 2).
28. Here, we define “standard” transfection as a method
entailing the addition of the plasmid DNA and transfection
reagent mixture in a drop-wise manner to the adherent
293FT cells that have been seeded at a final viable cell
concentration of 2.5 × 105 a day before. mCRITICAL STEP
The DNA-lipid complex should be added in a drop-wise
manner and distributed homogenously to the adhered cells
in the culture dish by gentle swirling without disturbing the
adhered cells (Figure S4B).
29. The “double” transfection refers to the combination of both
“standard” and “reverse” methods in the following sequence:
reverse transfection and incubates overnight, followed by
standard transfection on the following day.
30. Incubate the cells at 37◦C overnight in a 5% CO2 humidified
growth incubator.
In vivo Fluorescence Labeling, Imaging,
and Quantification (60 Min)
31. Use the LumioTM Green In-Cell Labeling kit to detect the
expression of AtGORK-cLumioTM in 293FT cells following
the manufacturer’s instructions. Label the cells transfected
with AtGORK-cLumioTM expression vector obtained in step
30 with 1.25µM of LumioTM Green. Incubate the cells
at 37◦C for 30min, protected from light.  CAUTION
LumioTM Green is a biarsenical labeling reagent, specifically
recognizes and binds to the tetracysteine LumioTM tag,
which strongly fluoresces upon binding to the LumioTM tag.
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TABLE 2 | Troubleshooting.
Step Parameters Recommendation Comments
3 Plasmid and label Vivid ColorsTM
pcDNATM6.2/EmGFP-
DEST Gateway®
vector
EmGFP improves
expression of
AtGORK and reduces
background noise
signal (Martin et al.,
2005)
4 Codon optimization GeneOptimizer®
software by
ThermoFisher
Scientific
Maximizes the
expression of
AtGORK in the
mammalian
expression system
19 Amount of cells 2.5× 105 cells/2mL Suitable seed amount
to achieve
well-spaced single
cells
25 Coating of cover slip Overnight coating
with Poly-D-lysine
Poly-D-lysine is
preferred over
poly-L-lysine because
poly-D-lysine is not
digestible
26 Amount of plasmid 2.5µg Higher plasmid
amount did not
significantly improve
transfection efficiency
and may be toxic to
cells (Lin et al., 2015;
Figure S2)
26 Transfection reagent Lipofectamine® 3000 Lipofectamine® 3000
outperforms
Lipofectamine® 2000
and FuGENE® HD
27 Transfection protocol “Reverse” “Reverse”
transfection protocol
saves one additional
day and is generally
preferred for
single-cell
applications as
compared to the
“standard”
transfection
34 Detection GFP fluorescence Requires
fluorescence
microscopy with
fluorescence GFP
filters
Practice safe precautionary measures by wearing protective
clothing, eyewear, and nitrile gloves when handling the
LumioTM Green reagent. mCRITICAL STEP Prepare fresh
LumioTM Green solution just before use and keep the
solution at room temperature in dark, protected from light.
32. Upon incubation, gently remove the LumioTM labeling
solution and wash cells once with OPTI-MEM R© I medium.
Carefully remove and discard the medium.
33. Gently add 20µM of Disperse Blue 3 solution that is
supplied with the LumioTM In-Cell labeling kit following the
manufacturer’s protocol to each well. mCRITICAL STEP Do
not remove the solution and proceed to fluorescence imaging
to detect the labeled AtGORK-cLumioTM in the presence
of Disperse Blue 3 solution to reduce the high background
fluorescence (Adams et al., 2002).  CAUTION Disperse
Blue 3 solution is a non-fluorescent, hydrophobic dye that
may results in eye, and skin irritation. Wear protective
clothing, eyewear and nitrile gloves when handling with
the solution. • OPTIONAL Due to high background signal
resulted from LumioTM Green staining, a stringent washing
procedure can be carried out by adding low concentrations
of thiol-containing reagent using β-mercaptoethanol that
competitively binds to the thiol-binding site thereby
increasing the specific labeling of the LumioTM-tagged
proteins (Langhorst et al., 2006).
34. Detect expression of AtGORK-EmGFP directly in 293FT
cells transfected with AtGORK-EmGFP plasmid by
fluorescence microscopy using the green fluorescence
filter at the excitation wavelength from 460 to 500 nm.
mCRITICAL STEP Both pcDNATM6.2/nLumioTM-
GW/p64 and Vivid Colors pcDNA6.2/C-terminal tagged
EmGFP/GW/CAT plasmids are used as the positive control
for transfection efficiency. v Troubleshooting (Table 2).
35. Capture three bright-field images from three randomly
chosen locations under a 20 × objective lens. Capture also
three fluorescence images under the same viewing fields
to calculate the percentage of transfection efficiency. On
average, a fluorescence image contained several hundred
green cells.
36. Using Image J (Schneider et al., 2012), process and analyse
the fluorescence and bright-field images according to the
methods described previously (Lin et al., 2015) in order
to determine the transfection efficiency and the expression
levels. Each fluorescence image contains 2560 × 1920 pixels
and each is assigned a value ranging from 0 to 255 on an 8-bit
digital scale using Image J. mCRITICAL STEP Each green
fluorescent cell detected represents successful transfection
and protein expression.
37. We define transfection efficiency as the number of cells that
have fluorescence detectable above background divided by
the total number of cells calculated on the corresponding
bright-field images and is expressed as a percentage.
38. We estimate the relative expression levels of the protein
by measuring the fluorescent intensities (in pixels) of the
green fluorescent cells with the assumption that the protein
expression in each individual cell is linearly proportional to
the amount of the reporter EmGFP or LumioTM tag that the
cell expressed (Lin et al., 2015).
RNA Extraction, cDNA Synthesis and PCR
(1-2 Days)
39. Perform total RNA extraction followed by cDNA synthesis
from the transfected cells obtained in step 30 as described
previously (Sagar et al., 2014).
40. Gently wash the transfected cells twice with 2mL of cold 1X
PBS solution. Discard the PBS solution.
41. Add 600µL of TRIzol R© reagent to the cells and incubate
at room temperature for 5min to allow cell lysis to occur.
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Gently transfer the cells from the 6-well culture dish to
1.5mL microcentrifuge tubes.
42. Add 120µL of chloroform to the lysed cells and gently invert
the tubes for 15 s. Incubate on ice for 10min. Centrifuge at
8000 rpm at 4◦C for 15min.
43. Separate the aqueous phase and transfer to new sterile
1.5mL microcentrifuge tubes. Add 300µL of 2-Propanol
to the aqueous phase and incubate at −20◦C overnight to
precipitate the RNA.
44. The following day, centrifuge at 8000 rpm at 4◦C for 30min.
Discard the supernatant.
45. Wash the pellet with 600µL of 75% (v/v) ethanol. Centrifuge
at 8000 rpm at 4◦C for 20min. Discard the supernatant.
Air-dry the pellet by placing the tube with the lid opened
under the laminar hood. Dissolve the pellet in 30µL of
DEPC-treated water.
46. Quantify the total RNA concentration using a Nanodrop.
Store the RNA at−80◦C.
47. For synthesis of cDNA, set up a reaction tube consisting of
3µg of RNA obtained in step 46, 250 ng of Oligo-dT primer
and 500µM of dNTPs. Incubate the reaction at 65◦C for
5min followed by a brief centrifugation and terminates the
reaction by incubating the tube on ice.
48. Set up a cDNA reaction using the Applied BiosystemsTM
High-Capacity cDNA Reverse Transcription Kit by adding
1X first strand reaction Buffer, 5mM DTT, 200 units
SuperScript III RT, and 40 units of RNAse to a final
reaction volume of 20µL and run the reaction following the
manufacturer’s protocol. Store the cDNA at−20◦C.
49. Perform PCR using the KAPA Taq PCR kit, designed
AtGORK PCR forward and reverse primers (Table 3) and
PCR cycles according to the manufacturer’s instructions to
determine the heterologous expression of AtGORK in 293FT
cells.
Current-Voltage Recording and Analysis
(60min)
50. Perform whole-cell voltage-clamp recordings from 293FT
cells transfected with AtGORK-cLumioTM and AtGORK-
EmGFP plasmids respectively, obtained in step 30 as
described previously (Lemtiri-Chlieh and Ali, 2013).
51. Using a P-1000 FLAMING/BROWN micropipette puller,
make patch-recording pipettes by pulling the pipette from
TABLE 3 | Primers and PCR conditions.
Primer name Sequence (5′–3′) Tm (◦C) No. of cycle
AtGORK long
forward
GGTTCAAACACAGAGAGGTTCAG 62 40
AtGORK long
reverse
TAATTCACGCAAGCTTGACG 62 40
AtGORK
short forward
GGATCAGAAGAGAGTGTGACGTT 62 40
AtGORK
short reverse
CCCTTCAGAAGCCGCG 62 40
thick/standard wall borosilicate glass capillaries. Place the
micropipettes in the microforge holder and apply one or two
brief heat pulses to smooth the pipette tip.
52. Carefully place one of the coverslips containing the
transfected cells obtained in step 30 in the chamber. Find
and choose a single healthy cell to patch under the inverted
fluorescence microscope.
53. Perform the perfusion system by filling the external 60mL
syringes with external bath solution. Ensure that there is no
air bubble entrapped in the system and that the perfusion
is running smoothly at∼1–2mL/minute. mCRITICAL STEP
Avoid flooding the chamber as the salt in the bath medium
can precipitate and thus damage the microscope optics.
54. Fill the recording pipette prepared in step 51 with an
intracellular solution and gently tap out any entrapped air
bubbles. Apply positive air pressure in the pipette using 1mL
syringe and ensure that the electrode resistance is between 3
and 5M. mCRITICAL STEP Air bubbles prevent closing of
the electronic circuit resulting in a high resistance reading.
The internal solution is slightly hypo-osmotic as compared
to the bath medium to facilitate the high resistance seal
formation.
55. Upon achieving whole-cell configuration, hold the cells
at−52mV.
56. Start recording the K+ channel current using the voltage-
clamp protocol which consists of a series of 1000ms long
squared voltage depolarization between +120 to −80mV
in−20mV decrements. mCRITICAL STEP Cells transfected
with pcDNATM6.2/nLumioTM-GW/p64 and Vivid Colors
pcDNA6.2/C-terminal tagged EmGFP/GW/CAT plasmids
respectively, are used as the negative control for whole-
cell recording. To differentiate between intrinsic K+ and
AtGORK currents, AtGORK conductance was estimated as
the difference between steady-state currents (mean current
between 900 and 1000ms after depolarization) and the
current measured in the range of 40–60ms from the
beginning of the voltage test.
57. Use the MultiClampTM 700B microelectrode amplifier to
investigate the voltage clamp and current clamp recordings.
mCRITICAL STEP All signals were low-pass filtered at 2 kHz
before analog-to-digital conversion and were uncorrected
for leakage current or capacitive transients.
58. Analyze the data with pClamp software (version 10, Axon
Instruments Inc., California, USA) and express the data as
mean± standard error mean.
Statistical Analysis
59. Perform statistical analysis using the Student’s t-test with
Microsoft Excel 2010. Set the significance to a threshold
of P < 0.05 and n-values represent number of biological
replicates.
RESULTS AND DISCUSSION
Here, we examine several currently used transfection reagents
and in-cell fluorescent labeling and detection methods for
transient expression of membrane proteins in HEK-293 cells.
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We provide a generally applicable transfection procedure
for the expression of membrane proteins for current-voltage
measurements using the A. thaliana guard cell outward-
rectifying K+ channel, AtGORK (At5G37500) as an example and
discuss the potential pitfalls as well as the general considerations
that must be carefully noted throughout the experimental
workflow.
An AtGORK-cLumioTM Tag Fusion has
Lower Transfection Efficiency than
AtGORK-EmGFP
In order to select for single cell expressing the channel
protein for current-voltage measurement, fluorescent labels were
used as indicators for expression of the AtGORK channel
in the 293FT cells. We incorporated AtGORK with either
a LumioTM tag (a molecular weight of 585 Da) which is a
6 amino acid long cysteine-rich tag separated by a gap of
27 amino acid residues (Figure S1A) or fused the protein
with the Emerald Green Fluorescent Protein (EmGFP) of
27 kDa derived from A. victoria GFP at 7 amino acid residues
downstream of the C-terminal of AtGORK (Figure S1B).
When designing the protein linker, factors such as the length,
hydrophobicity and the number of amino acid residues to
yield specific structural conformations (e.g., coiled or sheet)
that can mitigate structural constrains and thus protein
functionality must be considered (for a comprehensive review
see: (Chen et al., 2013; Chichili et al., 2013). The LumioTM
tag contains a tetracysteine motif (Cys-Cys-Pro-Gly-Cys-Cys)
that forms an arsenical hairpin detectable by interactions
with the membrane-permeant fluorogenic biarsenical labeling
reagents (e.g., LumioTM Green or LumioTM Red) that strongly
fluoresces upon binding, thus, enabling labeling and detection
of LumioTM-tagged proteins with high specificity and affinity.
Cells transfected with the manufacturer-supplied positive control
plasmid pcDNATM6.2/nLumioTM-GW/p64 (Figures 1A,B) which
is a nucleus-localized transcription factor (human c-myc), have
poor transfection efficiency with <50% of cells expressing the
p64 protein, as indicated by the green fluorescence upon labeling
with LumioTM Green labeling reagent across all three biological
replicates. However, the efficiency was reduced to <5% for
AtGORK-cLumioTM expressed in HEK-293 cells. Upon labeling
with LumioTM green reagent, the intensity of green fluorescence
that correlates with the amount of p64-LumioTM tagged protein
expressed in the transfected cells is around 30–40 pixels while
those cells expressing the AtGORK-cLumioTM channel has <
20 pixels (Figure 1C). Since we detected mRNA transcript of
AtGORK-cLumioTM in the transfected cells (Figure S3), the low
fluorescence intensity observed is likely due to a poor copy
number of AtGORK protein expressed in the cells and/or poor
detection resolution resulting from non-specific binding of the
LumioTM reagent to the cells which reduces the fluorescent signal-
to-noise ratio. To reduce the high background, we performed
a washing procedure using the recommended 1X Disperse
Blue 3 solution. In addition, we also performed a stringent
washing procedure by adding low concentrations of thiol-
containing reagent using β-mercaptoethanol that competitively
bind the thiol-binding site thereby increasing the specific
labeling of the LumioTM-tagged proteins (Langhorst et al.,
2006). These procedures however do not overcome the problem
of the high background fluorescence, but reduce the specific
labeling and hence the overall staining efficiency of the
Lumio-tagged proteins. On the other hand, cells transfected
with the AtGORK-Vivid ColorsTM pcDNATM6.2/EmGFP-DEST
Gateway R© construct yield a higher number of transfected
cells (55%) and pixel intensity (80) (Figure 1D). This suggests
firstly, that a fluorescent protein fusion enhances the expression
efficiency of AtGORK channel in the HEK-293 cells and/or
secondly, that the brightness of EmGFP results in better contrast
in terms of resolution in detection and identification of protein
of interest due at least in part to the reduced background noise
signal (Martin et al., 2005). This AtGORK-EmGFP yields a two-
folds higher pixel intensity than that of cells transfected with
AtGORK-cLumioTM plasmid although the transfection efficiency
is only marginally higher (1.5-fold), suggesting that in addition
to an improved AtGORK protein expression in a fused GFP
configuration, the detection resolution is markedly improved
and this is consistent with previous reports (Martin et al., 2005)
that observed a 90% improved contrast for GFP detection over
biarsenic labels. This point is further supported by the fact that
the expression ofmembrane spanning AtGORK-EmGFP channel
yielded a pixel intensity that is higher than that of the soluble
p64 transcription factor protein labeled with the LumioTM system
(Figure 1D). Therefore, we recommend the EmGFP-fusion
configuration for the expression and identification of channel
proteins in 293FT cells by fluorescence detection methods since
the improved contrast is critical for single-cell selection and
patch-clamp studies in addition to an improvement in the protein
expression efficiency.
Since the expression vector contains both the target gene and
the fluorescent marker, cells that appear fluorescent therefore
provide direct indication of the expression and localization of
the target protein in the cells. This is in contrast to the co-
transfection method in which the expression of the marker gene
(CD8-alpha or a fluorescent protein) may not have a correlation
to the success of transfection efficiency and the targeted protein
expression level. However, the fluorescent tag or protein fusion
may impose structural constrains that can be detrimental to
the functionality of the protein of interest (Giepmans et al.,
2006). Here, we generated a construct in which AtGORK is
fused with the EmGFP at the C-terminal and separated by a 7
amino acid spacer. The EmGFP reporter is located at 519 amino
acids away from the annotated transmembrane regions that form
the channel pore at the N-terminal of AtGORK (Figure S1B),
and this presumably provides a sufficient spatial separation to
avoid structural constrains that may interfere with the biological
activity of the channel protein. To validate the functionality
of the channel activity of AtGORK, we selected single green
fluorescent cells for current-voltage measurements and show
that the typical transmembrane whole-cell current recordings
of AtGORK (IGORK) were obtained (Figure 2). Current-voltage
relationship (from +120 to −80mV in -20mV increments)
profiles were generated from the recorded IGORK (Figure 2Cii).
We also measured currents for non-transfected, single HEK-293
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FIGURE 1 | Transfection and expression efficiencies of AtGORK tagged with LumioTM and AtGORK fused with EmGFP in HEK-293 cells. (A) HEK-293
cells transfected with AtGORK-cLumioTM expression vector has reduced transfection efficiency as compared to the expression of the positive control p64 that is
consistent across all three biological replicates. (B) Representative images showing the poor transfection efficiency of cells transfected with AtGORK-cLumioTM and
the p64 positive control plasmids. (C) The expression of AtGORK in green fluorescence cells is lower than that of p64 using the LumioTM system as determined by
their pixel intensities. (D) The AtGORK-EmGFP has a higher transfection efficiency and protein expression than that of the nLumioTM-tagged p64 in HEK-293 cells. A
typical 20 × magnification of 293FT cell image contains 2560× 1920 pixels and is converted to an 8-bit byte image based on a scale of 0–255 using ImageJ
(Schneider et al., 2012). The lower limit cut-off representing appreciable and above background fluorescence, was set at 10 pixels. Transfection efficiency and protein
expression of more than 100 cells in each viewing field were analyzed (see Section Procedure for analysis).
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cells (Figure 2B). These intrinsic currents were shown to be a
mixed population of outward-rectifying K+ channel endogenous
to the HEK-293 cell (Jiang et al., 2002). Though, they are
easily recognizable, as they tend to show fast activation and
relatively slower inactivation kinetics upon depolarization. On
the other hand, IGORK measured from the cells transfected
with AtGORK-EmGFP plasmid demonstrate channel activation
with distinctive kinetics (Figure 2C) which are comparable to
the known delayed outwardly-rectifying K+-current recorded
from either A. thaliana guard protoplasts or from X. laevis
oocytes expressing AtGORK (Ache et al., 2000; Hosy et al.,
2003). One can therefore easily distinguish the true voltage and
time-dependent activated IGORK from the other native currents
(Figures 2B,C). Therefore, the GFP fusion in this configuration
does not alter the functionality of the channel expressed in
HEK-293 cells whereas a fusion protein that is very close to
the functional domain (e.g., channel pore, catalytic center, or
ligand-binding site) is more likely to disrupt the structure or
biological activity of the protein (Hoffmann et al., 2010). In
some cases, the maturation time of fluorescent proteins may
be a limiting factor especially when studying rapid protein-
ligand or protein-protein interactions (Snapp, 2005). While
the use of a smaller label such as the membrane-permeant
fluorogenic biarsenical dye fluorescein arsenical hairpin binder
(F1AsH) or the alternative red-shifted resorufin arsenical hairpin
binder analog (ReAsH) can conceivably overcome structural and
the concomitant functionality concerns, these epitopes require
labeling with biarsenical dyes that may be toxic to the cells. In
addition, non-specific binding of the dye to the hydrophobic
regions of the membrane in the cells is commonly associated
to the problem of high background staining which may be
overcome by an additional washing procedure upon labeling
(Martin et al., 2005). Still, in our case, we did not notice a
significant improvement in the staining efficiency even after
washing. Furthermore, the washing procedure involving thiol-
containing reagents may damage the cells and alternative protein
functions (Langhorst et al., 2006). The contrast and cytotoxicity
issues commonly associated with the LumioTM reagents have
been discussed elsewhere (Hoffmann et al., 2010).
Assessment of Commonly Used
Transfection Reagents
In order to evaluate the performance of current commercially
available transfection reagents, we transiently transfected the
293FT cells with the AtGORK-EmGFP construct using the
standard lipid-mediated transfection reagents, Lipofectamine R©
2000, Lipofectamine R© 3000, and non-liposomal FuGENE R©
HD formulation in a “reverse” format (see Section Procedure
for definition). Lipofectamine R© 3000 consistently outperform
Lipofectamine R© 2000 and FuGENE R© HD in transfection
efficiency, achieving approximately a 70% transfection rate with
AtGORK-EmGFP in comparison to the other two reagents
which achieved a rate of about 50% (Figures 3A,B). The
transfected cells exhibit an intensity of green fluorescence that
corresponds to the expression levels of AtGORK-EmGFP and is
consistently higher when transfected using the Lipofectamine R©
3000 or FuGENE R© HD as compared to the Lipofectamine R©
2000 (Figure 3C). This suggests that while FuGENE R© HD
yields lower transfection efficiency than Lipofectamine R©
3000, the protein expression level is comparable to that of
Lipofectamine R© 3000.
We observed a marked decline in transfection efficiency
when the reagents are left at room temperature for prolonged
periods of time. We note that the Lipofectamine R© and
FuGENE R© HD formulations should be stored at 4◦C and
should be used immediately after the reagents have been
equilibrated to room temperature. Furthermore, it is important
to incubate these transfection reagents for the durations and
at conditions recommended by their respective manufacturers
prior to addition to cells (Table 1). We also noted that these
incubation times and conditions should be adhered to as
strictly as possible since prolonged incubation times decrease
transfection efficiencies. Our results suggest that Lipofectamine R©
3000 outperforms Lipofectamine R© 2000 and FuGENE R© HD
in transfection efficiency and/or protein expression, which is
consistent with the claims of the manufacturer who reported it
for HEK-293, HeLa, LNCaP, HepG2, and A549 cell lines, the
superiority of Lipofectamine R© 3000.
Comparison of Different Transfection
Protocols
The three transfection protocols, “standard,” “reverse,” and
“double” (see Section Procedure for definition), were also
evaluated for their transfection and expression efficiencies
of AtGORK channel in 239FT cells using the Vivid
ColorsTM pcDNATM6.2/EmGFP-DEST Gateway R© plasmid
and Lipofectamine R© 3000 reagent. The “reverse” and
“double” transfections have similar transfection efficiencies
and protein expressions levels (Figure 4). Their transfection
efficiency of around 60% is lower than that achieved with the
“standard” transfection (80%) in two of the three biological
replicates (Figures 4A,B) while only in one of three biological
replicates, the “standard” transfection had higher protein
expression as deduced from the fluorescence intensities
(Figure 4C).
The “standard” transfection protocol while resulting in
better transfection efficiency, requires one additional day as
compared to the “reverse” transfection because the cells are
seeded overnight before the addition of Lipofectamine R© 3000
reagent and the AtGORK-EmGFP plasmid. Since the cells
are allowed to grow for an additional day in the “standard”
transfection method, more cells are clumped together and this
may complicate single-cell selection for patch-clamp studies.
These factors, such as the transfection efficiency, time and cell
morphology should be considered case-by-case basis depending
on the intended application. As for the transfection of membrane
proteins or ion channels in HEK-293 cells, we recommend
the “reverse” transfection protocol starting with a seed number
of approximately 250,000 cells in a total volume of 2mL.
The “double” transfection protocol may be useful for the
transfection of large plasmids (>10 kb) or choice of cell lines
that usually have low transfection efficiency in single transfection.
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FIGURE 2 | Whole-cell current-voltage measurements of AtGORK-EmGFP in 293FT cells. (A) Bright field and fluorescence images of (i) 293FT and (ii)
AtGORK-EmGFP—expressing 293FT single cell at 20 × magnification field view (scale bar = 20µm). 293FT cells were transfected with 2.5µg of Vivid ColorsTM
pcDNATM6.2/EmGFP-DEST Gateway® expression vector containing the AtGORK insert using Lipofectamine® 3000 in a “reverse” format (see Section Procedure for
description). (B) Voltage- and time-dependent (i) and I-V plot (ii) properties of the intrinsic K+ channels in HEK-293 cells in response to a series of depolarizing square
pulse (from a holding potential, HV = −52mV in 20mV increments). Inset: A current showing the fast activation and relatively slower inactivation kinetics of intrinsic
K+ currents upon depolarization. (C) Whole-cell patch-clamp recordings (i) and I-V plot (ii) of intrinsic K+ and AtGORK channels currents, starting from HV = −52mV
in 20mV increments in AtGORK-EmGFP—expressing 293FT single cell. Inset: A representative current demonstrating the slowly activating outward currents of
AtGORK upon depolarization.
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FIGURE 3 | Comparison of different transfection reagents on the transfection and expression efficiencies of AtGORK-EmGFP in HEK-293 cells.
HEK-293 cells transfected with AtGORK-EmGFP were used to examine the performance of different transfection reagents in a “reverse” format (see Section
Procedure for definition). In general, Lipofectamine® 3000 outperforms Lipofectamine® 2000 and FuGENE® HD in both transfection efficiency (A,B) and protein
expression (C). Lipofectamine® 2000 and FuGENE® HD have comparable transfection efficiencies but lower than that of Lipofectamine® 3000. FuGENE® HD seems
to yield protein expression levels comparable to that of Lipofectamine 3000. A typical 20 × HEK cell image contains 2560× 1920 pixels and is converted to an 8-bit
byte image that on a scale of 0–255 using ImageJ. The lower limit cut-off that represents appreciable and above background fluorescence, was set at 10 pixels for
biological replicate 1 but 40 pixels for replicates 2 and 3. Transfection efficiency and protein expression of more than 200 cells in each viewing area were analyzed (see
Section Procedure for analysis).
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FIGURE 4 | Effect of different transfection methods on the transfection and expression efficiencies of AtGORK-EmGFP in HEK-293 cells. HEK-293 cells
transfected with AtGORK-EmGFP were used to examine the performance of different transfection format: “standard,” “reverse,” and “double” (see Section Procedure
for definition) using the Lipofectamine® 3000 reagent. The “standard” transfection method outperforms both the “reverse” and “double” transfection format
respectively, in 2 out of 3 biological repeats in terms of transfection efficiency (A,B). The “standard” transfection protocol yields higher protein expression levels in only
1 biological replicate but yield comparable expression levels to the other transfection methods in replicates 2 and 3 (C). A typical 20 × HEK cell image contains
2560× 1920 pixels and is converted to an 8-bit byte image that is on a scale of 0–255 using ImageJ. The lower limit cut-off representing appreciable and above
background fluorescence, was set at 10 pixels for 40 pixels. Transfection efficiency and protein expression of more than 100 cells in each viewing field were analyzed
(see Section Procedure for analysis).
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However, we noted that in the transfection of 293FT cells
with AtGORK-EmGFP, the efficiency did not improved with the
double transfection protocol since an optimal uptake of plasmids
may already have been achieved in single transfection.
A General Protocol for the Expression of
Membrane Proteins in HEK-293 Cells for
Current-Voltage Measurements
We detail optimized experimental parameters (Table 2) for high
expression of AtGORK channel in 293FT cells for single-cell
applications such as electrophysiological characterization
and describe the experimental workflow (Figure S4). This
authoritative step-by-step protocol serves as a good platform
from that, users can conduct informed and less risky targeted
optimizations, thus benefiting first time users or those with
proteins of unknown properties. Based on this protocol, rational
changes can be made in particular to the design of expression
vectors with suitable identification tags, as well as the choice of
transfection reagents and experimental parameters in order to
cater for the expression of membrane proteins in general and/or
for other functional characterizations.
In summary, we have described an optimized protocol
that serves as a general guide for the transient transfection
and expression of a membrane protein in HEK-293 cells
for functional characterizations in general and single-cell
applications in particular. We demonstrate that the use
of a GFP-fused expression construct, Vivid ColorsTM
pcDNATM6.2/EmGFP-DEST Gateway R© vector at 2.5µg
using Lipofectamine R© 3000 reagent in a “reverse” format yields
a high transfection efficiency, protein expression level as well
as optimal detection of AtGORK channels in 293FT cells. We
also recommend experimental parameters amendable for other
applications including cautionary steps associated with this
protocol. We believe that this optimized method will facilitate
the physiological and cellular characterization of complex
membrane proteins.
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Figure S1 | Design of AtGORK (At5G37500) plasmid construct. (A) Domain
organization of full-length Arabidopsis thaliana GORK (AtGORK) (At5G37500)
channel and the insertion of the AtGORK gene into pcDNATM6.2/cLumioTM-
DEST. (B) Domain organization of full-length Arabidopsis thaliana GORK (AtGORK)
(At5G37500) channel and the insertion of the AtGORK gene into Vivid ColorsTM
pcDNATM6.2/EmGFP-DEST Gateway® vector.
Figure S2 | Comparison of different amount of AtGORK-cLumioTM
plasmid for transfection.
Figure S3 | mRNA transcript of AtGORK-cLumioTM heterologously
expressed in HEK-293 cells.
Figure S4 | Experimental workflow for heterologous expression of
membrane proteins in HEK-293 cells for electrophysiological
characterizations. (A) Plasmid design and label selection. (B) Transfection and
expression. (C) Fluorescent imaging and quantification. (D) Current-voltage
measurement and data analysis.
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